A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, 60-Week, Phase II Clinical Trial of Three Re-Purposed Medications in Moderate Severity Parkinson’s Disease

  • Rowe, Dominic (Primary Chief Investigator)
  • Gan, Richard (Research Coordinator)

    Project: Research

    Project Details

    Short titleAPM001
    StatusActive
    Effective start/end date10/09/20 → 29/07/25